Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico.-论文-万方医学网

第一作者： Lisa M,Dunkle

第一单位： From Novavax, Gaithersburg (L.M.D., G.A., K.S., W.W., I.C., G.M.G., F.D.), the University of Maryland School of Medicine, Baltimore (K.L.K., M.A.M., K.M.N.), the National Institute of Allergy and Infectious Diseases, Bethesda (J.H.), and Walter Reed Army Institute of Research, Silver Spring (J.A.A.) - all in Maryland; FAICIC Clinical Research, Veracruz (A.Q.B.H.), and Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City (G.M.R.-P.) - both in Mexico; Research Your Health, Plano (J.M.A.) and the Texas Center for Drug Development, Houston (V.G.-F.) - both in Texas; M3-Wake Research, Raleigh (W.L.H.), M3-Emerging Medical Research, Durham (D.B.M.), and the University of North Carolina School of Medicine, Chapel Hill (C.L.G.) - all in North Carolina; SIMEDHealth, Gainesville (D.M.D.), and Velocity Clinical Research, Hallandale Beach (B.E.S.) - both in Florida; the University of Nebraska Medical Center, Omaha (D.F.F.); the University of Washington Medical Center (R.S.M., R.W.C., A.L.G.) and Fred Hutchinson Cancer Research Center (L.C.), Seattle, and Lummi Indian Health Center, Bellingham (D.C.L.) - all in Washington; the Atlanta Center for Medical Research, Atlanta (R.A.R.), and IACT Health, Columbus (J.K.K.) - both in Georgia; Velocity Clinical Research-Providence, Warwick, RI (D.L.F.); WR ClinSearch, Chattanooga, TN (M.M.); MedPharmics, Metairie, LA (R.J.J.); and Black Hills Center for American Indian Health, Rapid City, SD (J.A.H.).

作者： Lisa M,Dunkle ^[1] ; Karen L,Kotloff ^[1] ; Cynthia L,Gay ^[1] ; Germán,Áñez ^[1] ; Jeffrey M,Adelglass ^[1] ; Alejandro Q,Barrat Hernández ^[1] ; Wayne L,Harper ^[1] ; Daniel M,Duncanson ^[1] ; Monica A,McArthur ^[1] ; Diana F,Florescu ^[1] ; R Scott,McClelland ^[1] ; Veronica,Garcia-Fragoso ^[1] ; Robert A,Riesenberg ^[1] ; David B,Musante ^[1] ; David L,Fried ^[1] ; Beth E,Safirstein ^[1] ; Mark,McKenzie ^[1] ; Robert J,Jeanfreau ^[1] ; Jeffrey K,Kingsley ^[1] ; Jeffrey A,Henderson ^[1] ; Dakotah C,Lane ^[1] ; Guillermo M,Ruíz-Palacios ^[1] ; Lawrence,Corey ^[1] ; Kathleen M,Neuzil ^[1] ; Robert W,Coombs ^[1] ; Alex L,Greninger ^[1] ; Julia,Hutter ^[1] ; Julie A,Ake ^[1] ; Katherine,Smith ^[1] ; Wayne,Woo ^[1] ; Iksung,Cho ^[1] ; Gregory M,Glenn ^[1] ; Filip,Dubovsky ^[1] ; 2019nCoV-301 Study Group

作者单位： From Novavax, Gaithersburg (L.M.D., G.A., K.S., W.W., I.C., G.M.G., F.D.), the University of Maryland School of Medicine, Baltimore (K.L.K., M.A.M., K.M.N.), the National Institute of Allergy and Infectious Diseases, Bethesda (J.H.), and Walter Reed Army Institute of Research, Silver Spring (J.A.A.) - all in Maryland; FAICIC Clinical Research, Veracruz (A.Q.B.H.), and Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City (G.M.R.-P.) - both in Mexico; Research Your Health, Plano (J.M.A.) and the Texas Center for Drug Development, Houston (V.G.-F.) - both in Texas; M3-Wake Research, Raleigh (W.L.H.), M3-Emerging Medical Research, Durham (D.B.M.), and the University of North Carolina School of Medicine, Chapel Hill (C.L.G.) - all in North Carolina; SIMEDHealth, Gainesville (D.M.D.), and Velocity Clinical Research, Hallandale Beach (B.E.S.) - both in Florida; the University of Nebraska Medical Center, Omaha (D.F.F.); the University of Washington Medical Center (R.S.M., R.W.C., A.L.G.) and Fred Hutchinson Cancer Research Center (L.C.), Seattle, and Lummi Indian Health Center, Bellingham (D.C.L.) - all in Washington; the Atlanta Center for Medical Research, Atlanta (R.A.R.), and IACT Health, Columbus (J.K.K.) - both in Georgia; Velocity Clinical Research-Providence, Warwick, RI (D.L.F.); WR ClinSearch, Chattanooga, TN (M.M.); MedPharmics, Metairie, LA (R.J.J.); and Black Hills Center for American Indian Health, Rapid City, SD (J.A.H.). ^[1]

主题词青少年(Adolescent);成年人(Adult);老年人(Aged);人类(Humans);发病率(Incidence);男(雄)性(Male);墨西哥(Mexico);中年人(Middle Aged);单盲法(Single-Blind Method);美国(United States)

DOI 10.1056/NEJMoa2116185

PMID 34910859

发布时间 2024-05-17

检索历史清除

Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico.

The New England journal of medicine

相似文献

The New England journal of medicine

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico.

The New England journal of medicine

相似文献

The New England journal of medicine

相关期刊

检索历史清除